Envista Holdings Corp (NVST)

USD 16.99

(3.98%)

Total Debt Summary of Envista Holdings Corp

  • Envista Holdings Corp's latest annual total debt in 2023 was 1.65 Billion USD , up 8.14% from previous year.
  • Envista Holdings Corp's latest quarterly total debt in 2024 Q3 was 1.42 Billion USD , down -4.12% from previous quarter.
  • Envista Holdings Corp reported annual total debt of 1.52 Billion USD in 2022, up 4.74% from previous year.
  • Envista Holdings Corp reported annual total debt of 1.45 Billion USD in 2021, down -26.3% from previous year.
  • Envista Holdings Corp reported quarterly total debt of 1.64 Billion USD for 2024 Q2, down -0.2% from previous quarter.
  • Envista Holdings Corp reported quarterly total debt of 1.64 Billion USD for 2024 Q1, down -0.46% from previous quarter.

Annual Total Debt Chart of Envista Holdings Corp (2023 - 2017)

Historical Annual Total Debt of Envista Holdings Corp (2023 - 2017)

Year Total Debt Total Debt Growth
2023 1.65 Billion USD 8.14%
2022 1.52 Billion USD 4.74%
2021 1.45 Billion USD -26.3%
2020 1.98 Billion USD 28.82%
2019 1.53 Billion USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%

Peer Total Debt Comparison of Envista Holdings Corp

Name Total Debt Total Debt Difference
Alcon Inc. 5.14 Billion USD 67.849%
AptarGroup, Inc. 1.18 Billion USD -39.583%
Baxter International Inc. 14.36 Billion USD 88.488%
Becton, Dickinson and Company 15.87 Billion USD 89.586%
Bausch + Lomb Corporation 4.56 Billion USD 63.753%
Haemonetics Corporation 873.88 Million USD -89.224%
ResMed Inc. 873.93 Million USD -89.213%
Teleflex Incorporated 1.92 Billion USD 14.16%
Warby Parker Inc. 174.45 Million USD -847.855%
West Pharmaceutical Services, Inc. 309 Million USD -435.146%